By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
November 25, 2025 12:55 AM EST
Medical Herald
Search
  • Health Conditions
    Health ConditionsShow More
    Diet Drinks Linked to Increased Liver Disease Risk, Study Finds
    Health Conditions
    Experts Urge Rethink on Prediabetes Diagnosis and Treatment
    Diabetes
    Study Highlights Rising Heart Risks in Pregnant Women
    Pregnancy & Parenting
    ‘New Mom School’ Helps Women Through Postpartum Challenges
    Pregnancy & Parenting
    Beware of Counterfeit Weight Loss Drugs Sold Online
    Weight Management
  • Wellness & Self-Care
    Wellness & Self-CareShow More
    Heart Health: Simple Daily Habits for Everyone
    Heart Health
    Introducing the Hormometer: Track Cortisol at Home
    Wellness & Self-Care
    First Responders Turn to Ketamine for Mental Health Relief
    Mental Health
    Enjoy Healthy Living This Fall with a Delicious Protein Shake
    Healthy Living
    Top 3 Bedtime Yoga Poses for Better Sleep
    Wellness & Self-Care
  • Nutrition & Fitness
    Nutrition & FitnessShow More
    Fibermaxxing: The Rising Trend in Nutritional Focus
    Diet & Nutrition
    Gutzy Organic Launches Healthy Prebiotic Protein Smoothies
    Diet & Nutrition
    Achieve Your Nutrition Goals with Nourish and Insurance
    Nutrition & Fitness
    Delicious Roasted Salmon with Olives from Dan Pelosi
    Healthy Recipes
    Short Exercise Bursts: A New Trend in Fitness?
    Fitness
  • Innovation
    InnovationShow More
    Dr. Hosen Kiat: Advancing the Frontiers of Cardiovascular Science
    Innovation
    FDA Issues Warning for J&J and Legend’s Cancer Treatment Carvykti
    Drugs & Medications
    GLP-1 Medications Transform Health and Household Budgets
    Drugs & Medications
    Drug Tied to Fatal Crashes and Risks of Weight-Loss Pills
    Drugs & Medications
    GLP-1 Medications Like Ozempic May Affect Medical Scan Results
    Drugs & Medications
  • News
    NewsShow More
    Advances in Nigeria’s Real-Time NTD Treatment Reporting System
    News
    WIC Program Secures $300M Amid Government Shutdown Concerns
    News
    Guy Benson Shares Early Cancer Diagnosis and Encourages Skin Checks
    News Skin Care
    Congress Stalemate Threatens Health Insurance for Millions
    News
    Explorer Middle School Unveils New Gymnasium
    News
Font ResizerAa
Medical HeraldMedical Herald
  • Health Conditions
  • Wellness & Self-Care
  • Nutrition & Fitness
  • Innovation
  • News
Search
  • Health Conditions
  • Wellness & Self-Care
  • Nutrition & Fitness
  • Innovation
  • News
Follow US
Copyright © 2025, Medical Herald. All Rights Reserved.
Home » Innovation » How ALV-J Virus Bypasses Immune Defense Using miR-155

How ALV-J Virus Bypasses Immune Defense Using miR-155

By Samuel Lee
Published: October 27, 2025
Share

Avian leukosis virus subgroup J (ALV-J) is a significant oncogenic retrovirus that leads to severe health issues in poultry, including immunosuppression and the formation of tumors like myelocytomas. While previous research has established that ALV-J can evade innate immunity, the specific mechanisms behind this evasion have remained elusive. Recent studies reveal that ALV-J enhances the expression of microRNA-155 (miR-155), a key player in the suppression of immune responses, ultimately facilitating viral replication.

Contents
  • Author Summary
  • Introduction
  • miRNA and Immune Evasion
  • Experimental Findings
  • Conclusions
  • Data Availability
  • Funding
  • Keywords

In our research, we identified that the p27 viral protein from ALV-J significantly reduces the activity of a cellular protein called DEAD-box helicase 3X (DDX3X). This action diminishes DDX3X expression and promotes the maturation of the MIR155 host gene into active miR-155. The mature miR-155 then targets two crucial proteins, tumor necrosis factor receptor-associated factor 3 (TRAF3) and signal transducer and activator of transcription 1 (STAT1), both of which are essential for the initiation of type I interferon (IFN-I) responses. By silencing TRAF3 or STAT1, researchers found that ALV-J replication, which would normally be inhibited by miR-155, is restored.

This discovery marks a notable advance in understanding the immune evasion tactics employed by retroviruses such as ALV-J, shedding light on their complex pathogenesis.

Author Summary

ALV-J is known for causing considerable economic repercussions in the poultry industry due to its ability to disrupt immune function and induce tumors. Our study illuminates how ALV-J manipulates the host microRNA, miR-155, to escape the body’s antiviral responses. By compromising the function of DDX3X, ALV-J can increase miR-155 levels. This rise in miR-155, in turn, blocks the action of TRAF3 and STAT1—critical regulators in the immune response—thereby suppressing the production of interferons that would typically hinder viral replication. Through this mechanism, the virus effectively lowers its chances of being eradicated by the host immune system.

Introduction

ALV-J represents a rapidly evolving oncogenic retrovirus that poses significant health threats to poultry by inducing immunosuppression and neoplastic diseases. These conditions lead to reduced growth rates, susceptibility to infections, and overall productivity losses in affected flocks. The virus can spread both horizontally and vertically, with vertical transmission linked to more pronounced pathogenic effects, especially during early stages of a chicken’s life.

The ability of ALV-J to evade the host immune response is crucial for its infection and persistence. This evasion is facilitated by the virus’s unique strategies that exploit host factors, such as miRNAs, to counteract antiviral defenses. However, the underlying mechanisms by which ALV-J escapes immune detection remain less well-defined.

miRNA and Immune Evasion

miRNAs are small, non-coding RNAs that regulate gene expression. They play significant roles in both innate and adaptive immune responses, making them intriguing targets for viral immune evasion strategies. For instance, studies have shown that several oncogenic viruses effectively manipulate host miRNA functions to promote their own longevity and pathogenicity.

Our research highlights that while ALV-J induces various miRNAs, including miR-200b-3p, miR-34b-5p, and miR-23b, miR-155 is particularly prominent in the virus’s ability to escape immune responses. Elevated levels of miR-155 were found to block critical components of the host’s antiviral response, particularly affecting IFN production.

Experimental Findings

To explore how ALV-J influences miR-155 levels and subsequent immune suppression, CEFs (chicken embryo fibroblasts) were infected with ALV-J, revealing that infection led to a substantial increase in miR-155 levels. Notably, DDX3X was identified as a significant interacting partner that p27 protein of ALV-J targets to promote miR-155 maturation.

Following this, functional assays demonstrated that increasing miR-155 exerted a negative impact on ALV-J-induced IFN-β production, highlighting the intricate mechanism by which ALV-J manipulates the host immune response. Importantly, DDX3X overexpression was found to reverse the miR-155 induced decrease in TRAF3 and STAT1, confirming that these proteins are key targets for miR-155-mediated immune evasion during viral infections.

Conclusions

The findings establish a novel miR-155-dependent pathway whereby ALV-J sidesteps host immune defenses, ultimately promoting viral replication and persistence. This mechanism illustrates the complex dynamics of host-virus interactions and opens avenues for future research into potential therapeutic targets that could disrupt these viral evasion strategies.

Data Availability

All data supporting this research are provided in the manuscript and supplementary files.

Funding

This study received financial support from several sources, including the Natural Science Foundation of China and the Key Research and Development Program of Shandong Province.

Keywords

  • Avian leukosis virus subgroup J
  • miR-155
  • Innate immunity
  • TRAF3
  • STAT1
  • Viral replication

Diseases & Conditions

Share This Article
Facebook LinkedIn Email Copy Link
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

HOT NEWS

Dr. Hosen Kiat: Advancing the Frontiers of Cardiovascular Science

November 11, 2025

Diet Drinks Linked to Increased Liver Disease Risk, Study Finds

New research suggests both sugary and diet sodas may increase liver disease risk, urging experts…

November 11, 2025

FDA Issues Warning for J&J and Legend’s Cancer Treatment Carvykti

FDA warns of severe gut inflammation linked to Carvykti, a cancer therapy for multiple myeloma,…

November 11, 2025

GLP-1 Medications Transform Health and Household Budgets

GLP-1 drugs are revolutionizing weight loss—and personal finance. As health improves, Americans are rethinking budgets,…

November 11, 2025

YOU MAY ALSO LIKE

Quince Expands Product Line to Include Supplements

I tested Quince’s new wellness supplements—from protein to hydration blends. Here’s what’s worth it and what I’d skip.

October 3, 2025

Discovering My Sleep Patterns with SleepSpace App Insights

SleepSpace helped me uncover hidden sleep issues using just my phone and AI support—no wearables, just insights from Dr. Snooze…

October 3, 2025

Whoop App Introduces Blood Testing Feature for Users

Whoop expands into blood testing with Advanced Labs, integrating Quest Diagnostics results to connect daily fitness data with key health…

October 6, 2025

Steakholder Foods to Raise $1.5 Million Through Warrant Exercise

Steakholder Foods exercises warrants to raise $1.5M, fueling its alt-protein expansion and issuing new Series A & B warrants at…

October 3, 2025

Medical Herald is your trusted source for medical news, scientific research, health policy updates, and expert insights from around the world. 

Category

  • Health Conditions
  • Wellness & Self-Care
  • Nutrition & Fitness
  • Innovation
  • News
  • Privacy Policy
  • About Us
  • Contact

Follow US: 

  • Grow Big Agency Sites:
  • London Business Journal
Copyright © 2025, Medical Herald. All Rights Reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?